Mette Bøgelund Selected Research

Therapeutics

12/2021	Attitudes about the treatment of obesity among healthcare providers involved in the care of obesity-related diseases: A survey across medical specialties in multiple European countries.
1/2021	Preference for Immunotherapy with Tablets by People with Allergic Rhinitis.
8/2018	Patient awareness about family planning represents a major knowledge gap in multiple sclerosis.
1/2016	Patients' with type 2 diabetes willingness to pay for insulin therapy and clinical outcomes.
3/2013	Women's preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy.
9/2011	Willingness to pay for improvements in chronic long-acting insulin therapy in individuals with type 1 or type 2 diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mette Bøgelund Research Topics

Disease

4	Type 2 Diabetes Mellitus (MODY) 01/2021 - 09/2011
3	Allergic Rhinitis 02/2022 - 01/2021
3	Hypersensitivity (Allergy) 02/2022 - 01/2021
3	Weight Gain 01/2016 - 09/2011
2	Obesity 01/2022 - 12/2021
2	Weight Loss (Weight Reduction) 12/2021 - 01/2016
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 09/2011
2	Hypoglycemia (Reactive Hypoglycemia) 01/2013 - 09/2011
1	COVID-19 01/2021
1	Anaphylaxis (Anaphylactic Shock) 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 10/2018
1	Pain (Aches) 10/2018
1	Multiple Sclerosis 08/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2017
1	Body Weight (Weight, Body) 01/2016
1	Schizophrenia (Dementia Praecox) 01/2016
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2016
1	Atrophy 03/2013
1	Nausea 11/2011

Drug/Important Bio-Agent (IBA)

3	TabletsIBA 02/2022 - 01/2016
3	Insulin (Novolin)FDA Link 12/2017 - 01/2016
2	Hypoglycemic Agents (Hypoglycemics)IBA 12/2017 - 01/2013
2	Blood Glucose (Blood Sugar)IBA 11/2011 - 09/2011
1	Indicators and Reagents (Reagents)IBA 01/2017
1	Loxapine (Loxitane)FDA LinkGeneric 01/2016
1	Estrogens (Estrogen)FDA Link 03/2013
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 09/2011

Therapy/Procedure

6	Therapeutics 12/2021 - 09/2011
6	Injections 01/2021 - 09/2011
3	Immunotherapy 02/2022 - 01/2021
2	Nebulizers and Vaporizers (Inhaler) 01/2017 - 01/2016
1	Bariatric Surgery 01/2022
1	Length of Stay 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Mechanical Ventilators (Ventilator) 01/2021
1	Catheters 10/2018
1	Glycemic Control 12/2017